Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC.

Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, Sauter JL, Choi H, Tenet M, Abu-Akeel M, Plodkowski AJ, Perez-Johnston R, Yoo CH, Ko RB, Stehr H, Gojenola L, Wakelee HA, Padda SK, Neal JW, Chaft JE, Kris MG, Rudin CM, Merghoub T, Li BT, Alizadeh AA, Diehn M.

Clin Cancer Res. 2020 Feb 11. pii: clincanres.3418.2019. doi: 10.1158/1078-0432.CCR-19-3418. [Epub ahead of print]

PMID:
32046999
2.

The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.

Painter CA, Jain E, Tomson BN, Dunphy M, Stoddard RE, Thomas BS, Damon AL, Shah S, Kim D, Gómez Tejeda Zañudo J, Hornick JL, Chen YL, Merriam P, Raut CP, Demetri GD, Van Tine BA, Lander ES, Golub TR, Wagle N.

Nat Med. 2020 Feb;26(2):181-187. doi: 10.1038/s41591-019-0749-z. Epub 2020 Feb 10.

PMID:
32042194
3.

The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction.

Inda MC, Joshi S, Wang T, Bolaender A, Gandu S, Koren Iii J, Che AY, Taldone T, Yan P, Sun W, Uddin M, Panchal P, Riolo M, Shah S, Barlas A, Xu K, Chan LYL, Gruzinova A, Kishinevsky S, Studer L, Fossati V, Noggle SA, White JR, de Stanchina E, Sequeira S, Anthoney KH, Steele JW, Manova-Todorova K, Patil S, Dunphy MP, Pillarsetty N, Pereira AC, Erdjument-Bromage H, Neubert TA, Rodina A, Ginsberg SD, De Marco Garcia N, Luo W, Chiosis G.

Nat Commun. 2020 Jan 16;11(1):319. doi: 10.1038/s41467-019-14082-5.

4.

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.

Prockop S, Doubrovina E, Suser S, Heller G, Barker J, Dahi P, Perales MA, Papadopoulos E, Sauter C, Castro-Malaspina H, Boulad F, Curran KJ, Giralt S, Gyurkocza B, Hsu KC, Jakubowski A, Hanash AM, Kernan NA, Kobos R, Koehne G, Landau H, Ponce D, Spitzer B, Young JW, Behr G, Dunphy M, Haque S, Teruya-Feldstein J, Arcila M, Moung C, Hsu S, Hasan A, O'Reilly RJ.

J Clin Invest. 2020 Feb 3;130(2):733-747. doi: 10.1172/JCI121127.

5.

Paradigms for Precision Medicine in Epichaperome Cancer Therapy.

Pillarsetty N, Jhaveri K, Taldone T, Caldas-Lopes E, Punzalan B, Joshi S, Bolaender A, Uddin MM, Rodina A, Yan P, Ku A, Ku T, Shah SK, Lyashchenko S, Burnazi E, Wang T, Lecomte N, Janjigian Y, Younes A, Batlevi CW, Guzman ML, Roboz GJ, Koziorowski J, Zanzonico P, Alpaugh ML, Corben A, Modi S, Norton L, Larson SM, Lewis JS, Chiosis G, Gerecitano JF, Dunphy MPS.

Cancer Cell. 2019 Nov 11;36(5):559-573.e7. doi: 10.1016/j.ccell.2019.09.007. Epub 2019 Oct 24.

PMID:
31668946
6.

Pharmacokinetic assessment of 18F-(2S,4R)-4-fluoroglutamine in patients with cancer.

Grkovski M, Goel R, Krebs S, Staton KD, Harding JJ, Mellinghoff IK, Humm JL, Dunphy MP.

J Nucl Med. 2019 Oct 10. pii: jnumed.119.229740. doi: 10.2967/jnumed.119.229740. [Epub ahead of print]

PMID:
31601700
7.

Correction to: 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.

Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):4. doi: 10.1007/s00259-019-04514-1.

8.

18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.

Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R.

Eur J Nucl Med Mol Imaging. 2019 Aug 15. doi: 10.1007/s00259-019-04433-1. [Epub ahead of print] Erratum in: Eur J Nucl Med Mol Imaging. 2019 Sep 7;:.

PMID:
31418054
9.

Chaperome heterogeneity and its implications for cancer study and treatment.

Wang T, Rodina A, Dunphy MP, Corben A, Modi S, Guzman ML, Gewirth DT, Chiosis G.

J Biol Chem. 2019 Feb 8;294(6):2162-2179. doi: 10.1074/jbc.REV118.002811. Epub 2018 Nov 8. Review.

10.

Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologists.

Huicochea Castellanos S, Corrias G, Ulaner GA, Dunphy M, Junting Z, Capanu M, Balachandran V, Giancipoli RG, Monti S, Mannelli L.

Abdom Radiol (NY). 2019 Feb;44(2):586-592. doi: 10.1007/s00261-018-1765-z.

11.

Specialized second-opinion radiology review of PET/CT examinations for patients with diffuse large B-cell lymphoma impacts patient care and management.

Sawan P, Rebeiz K, Schoder H, Batlevi C, Moskowitz A, Ulaner GA, Dunphy M, Mannelli L.

Medicine (Baltimore). 2017 Dec;96(51):e9411. doi: 10.1097/MD.0000000000009411.

12.

In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine.

Dunphy MPS, Harding JJ, Venneti S, Zhang H, Burnazi EM, Bromberg J, Omuro AM, Hsieh JJ, Mellinghoff IK, Staton K, Pressl C, Beattie BJ, Zanzonico PB, Gerecitano JF, Kelsen DP, Weber W, Lyashchenko SK, Kung HF, Lewis JS.

Radiology. 2018 May;287(2):667-675. doi: 10.1148/radiol.2017162610. Epub 2018 Jan 31.

13.

Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.

Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M, Jones LW, Downey RJ.

Clin Radiol. 2018 May;73(5):505.e1-505.e8. doi: 10.1016/j.crad.2017.12.004. Epub 2018 Jan 6.

14.

Solitary Orbital Metastasis in Carcinoma Esophagus: Findings on Serial 18F-FDG PET/CT Scans.

Mahajan S, Dunphy MP, Haque S, Pandit-Taskar N.

Clin Nucl Med. 2018 Jan;43(1):19-22. doi: 10.1097/RLU.0000000000001892.

PMID:
29135612
15.

The Precision of Hepatic Arterial Infusion Scintigraphy as a Quantitative Biomarker of Tumor Microvasculature.

Dunphy M, Pandit-Taskar N, Fox JJ, Kemeny N.

AJR Am J Roentgenol. 2017 Jul;209(1):182-186. doi: 10.2214/AJR.16.17560. Epub 2017 May 24.

16.

Value of second-opinion review of outside institution PET-CT examinations.

Ulaner GA, Mannelli L, Dunphy M.

Nucl Med Commun. 2017 Apr;38(4):306-311. doi: 10.1097/MNM.0000000000000647.

17.

Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients.

Nic Dhonncha E, Clowry J, Dunphy M, Buckley C, Field S, Paul L.

Br J Dermatol. 2017 Dec;177(6):1752-1753. doi: 10.1111/bjd.15262. Epub 2017 Sep 26. No abstract available.

PMID:
28005276
18.

Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation.

Garcia B, Goodman KA, Cambridge L, Dunphy M, Wu AJ.

Radiat Oncol. 2016 Nov 25;11(1):156.

19.

Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Kim MM, Parolia A, Dunphy MP, Venneti S.

Nat Rev Clin Oncol. 2016 Dec;13(12):725-739. doi: 10.1038/nrclinonc.2016.108. Epub 2016 Jul 19. Review.

20.

The epichaperome is an integrated chaperome network that facilitates tumour survival.

Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, Pressl C, Peter RI, Xu C, Trondl R, Patel HJ, Shimizu F, Bolaender A, Yang C, Panchal P, Farooq MF, Kishinevsky S, Modi S, Lin O, Chu F, Patil S, Erdjument-Bromage H, Zanzonico P, Hudis C, Studer L, Roboz GJ, Cesarman E, Cerchietti L, Levine R, Melnick A, Larson SM, Lewis JS, Guzman ML, Chiosis G.

Nature. 2016 Oct 20;538(7625):397-401. doi: 10.1038/nature19807. Epub 2016 Oct 5.

21.

Radiosynthesis of the iodine-124 labeled Hsp90 inhibitor PU-H71.

Taldone T, Zatorska D, Ochiana SO, Smith-Jones P, Koziorowski J, Dunphy MP, Zanzonico P, Bolaender A, Lewis JS, Larson SM, Chiosis G, Pillarsetty NV.

J Labelled Comp Radiopharm. 2016 Mar;59(3):129-32. doi: 10.1002/jlcr.3369. Epub 2016 Jan 25.

22.

Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.

Chaft JE, Dunphy M, Naidoo J, Travis WD, Hellmann M, Woo K, Downey R, Rusch V, Ginsberg MS, Azzoli CG, Kris MG.

J Thorac Oncol. 2016 Apr;11(4):537-44. doi: 10.1016/j.jtho.2015.12.104. Epub 2015 Dec 25.

23.

Design and evaluation of a bioreactor with application to forensic burial environments.

Dunphy MA, Weisensee KE, Mikhailova EA, Harman MK.

Forensic Sci Int. 2015 Dec;257:242-251. doi: 10.1016/j.forsciint.2015.08.014. Epub 2015 Sep 7.

PMID:
26476697
24.

Prognostic Value of Preradiotherapy (18)F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer.

Ong LT, Dunphy M, Foster A, Woo KM, Zhang Z, Perez CA, Pietanza CM, Rosenzweig KE, Gelblum DY, Rimner A, Wu AJ.

Clin Lung Cancer. 2016 May;17(3):184-8. doi: 10.1016/j.cllc.2015.07.004. Epub 2015 Aug 3.

25.

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, Carlin SD, La Rocca G, Lyashchenko S, Ploessl K, Rohle D, Omuro AM, Cross JR, Brennan CW, Weber WA, Holland EC, Mellinghoff IK, Kung HF, Lewis JS, Thompson CB.

Sci Transl Med. 2015 Feb 11;7(274):274ra17. doi: 10.1126/scitranslmed.aaa1009.

26.

Static axial stretching enhances the mechanical properties and cellular responses of fibrin microthreads.

Grasman JM, Pumphrey LM, Dunphy M, Perez-Rogers J, Pins GD.

Acta Biomater. 2014 Oct;10(10):4367-76. doi: 10.1016/j.actbio.2014.06.021. Epub 2014 Jun 20.

27.

A Stability-Indicating HPLC Method for the Determination of Nitrosylcobalamin (NO-Cbl), a Novel Vitamin B12 Analog.

Dunphy MJ, Sysel AM, Lupica JA, Griffith K, Sherrod T, Bauer JA.

Chromatographia. 2014 Apr 1;77(7-8):571-589.

28.

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions.

Jhaveri K, Ochiana SO, Dunphy MP, Gerecitano JF, Corben AD, Peter RI, Janjigian YY, Gomes-DaGama EM, Koren J 3rd, Modi S, Chiosis G.

Expert Opin Investig Drugs. 2014 May;23(5):611-28. doi: 10.1517/13543784.2014.902442. Epub 2014 Mar 26. Review.

29.

MIRD pamphlet No. 24: Guidelines for quantitative 131I SPECT in dosimetry applications.

Dewaraja YK, Ljungberg M, Green AJ, Zanzonico PB, Frey EC; SNMMI MIRD Committee, Bolch WE, Brill AB, Dunphy M, Fisher DR, Howell RW, Meredith RF, Sgouros G, Wessels BW.

J Nucl Med. 2013 Dec;54(12):2182-8. doi: 10.2967/jnumed.113.122390. Epub 2013 Oct 15.

30.

Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm.

Nitadori J, Bograd AJ, Morales EA, Rizk NP, Dunphy MP, Sima CS, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2013 Dec;20(13):4282-8. doi: 10.1245/s10434-013-3212-2. Epub 2013 Aug 17.

31.

Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer.

Cuaron J, Dunphy M, Rimner A.

Front Oncol. 2013 Jan 3;2:208. doi: 10.3389/fonc.2012.00208. eCollection 2012.

32.

The effect of interactive neurostimulation therapy on myofascial trigger points associated with mechanical neck pain: a preliminary randomized, sham-controlled trial.

Schabrun SM, Cannan A, Mullens R, Dunphy M, Pearson T, Lau C, Chipchase LS.

J Altern Complement Med. 2012 Oct;18(10):946-52. doi: 10.1089/acm.2011.0142. Epub 2012 Aug 8.

PMID:
22873210
33.

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.

Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS.

Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30.

34.

High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.

Kadota K, Kachala SS, Nitadori J, Suzuki K, Dunphy MP, Sima CS, Travis WD, Rusch VW, Adusumilli PS.

J Thorac Oncol. 2012 Jul;7(7):1192-7. doi: 10.1097/JTO.0b013e3182519d96.

35.

18F-2-Deoxy-d-Glucose positron emission tomography-computed tomography in lung cancer.

Delappe E, Dunphy M.

Semin Roentgenol. 2011 Jul;46(3):208-23. doi: 10.1053/j.ro.2011.02.008. Review. No abstract available.

PMID:
21726705
36.

Dosimetry of 18F-labeled tyrosine kinase inhibitor SKI-249380, a dasatinib-tracer for PET imaging.

Dunphy MP, Zanzonico P, Veach D, Somwar R, Pillarsetty N, Lewis J, Larson S.

Mol Imaging Biol. 2012 Feb;14(1):25-31. doi: 10.1007/s11307-010-0462-2.

37.
38.

Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Dunphy MP, Lewis JS.

J Nucl Med. 2009 May;50 Suppl 1:106S-21S. doi: 10.2967/jnumed.108.057281. Epub 2009 Apr 20. Review.

39.

In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research.

Dunphy MP, Entenberg D, Toledo-Crow R, Larson SM.

Microvasc Res. 2009 Jun;78(1):51-6. doi: 10.1016/j.mvr.2009.03.008. Epub 2009 Apr 9.

40.

Molecular imaging of atherosclerosis.

Dunphy MP, Strauss HW.

Curr Cardiol Rep. 2008 Mar;10(2):121-7. Review.

PMID:
18417012
41.

Radionuclide techniques for identifying vulnerable plaque.

Dunphy MP, Schoder H, Strauss HW.

J Nucl Med. 2007 Nov;48(11):1753-5. No abstract available.

42.

Readers' responses to "must we fear adolescent sexuality?".

Dunphy M.

MedGenMed. 2005;7(2):37; author reply 36. No abstract available.

PMID:
16385717
43.

Association of vascular 18F-FDG uptake with vascular calcification.

Dunphy MP, Freiman A, Larson SM, Strauss HW.

J Nucl Med. 2005 Aug;46(8):1278-84.

44.

Imaging the vulnerable plaque: a scintillating light at the end of the tunnel?

Strauss HW, Dunphy M, Tokita N.

J Nucl Med. 2004 Jul;45(7):1106-7. No abstract available.

45.

Time-on-task data for cost-benefit analysis and formative evaluation in dietetics education.

Gilmer JS, Koury SD, Dunphy M.

J Am Diet Assoc. 1993 Aug;93(8):908-10. No abstract available.

PMID:
8335873
46.

Teaching dietetic interns to write for lay and professional audiences.

Dunphy M, Koury S.

J Am Diet Assoc. 1992 Mar;92(3):342-5.

PMID:
1552135
47.

Reliability of polymerase chain reaction in the detection of human immunodeficiency virus infection in children.

Petru A, Dunphy MG, Azimi P, Janner D, Gallo D, Hanson C, Sohmer P, Stanley M.

Pediatr Infect Dis J. 1992 Jan;11(1):30-3.

PMID:
1549405
48.

A postdischarge adverse drug reaction capture mechanism using medical record technicians.

Voris JC, Dunphy MP.

QRB Qual Rev Bull. 1991 Sep;17(9):293-6.

PMID:
1961653
49.
50.

Nitrate analysis by capillary gas chromatography.

Dunphy MJ, Goble DD, Smith DJ.

Anal Biochem. 1990 Feb 1;184(2):381-7.

PMID:
2327580

Supplemental Content

Loading ...
Support Center